Success Metrics

Clinical Success Rate
88.0%

Based on 22 completed trials

Completion Rate
88%(22/25)
Active Trials
2(6%)
Results Posted
14%(3 trials)
Terminated
3(9%)

Phase Distribution

Ph phase_3
11
33%
Ph phase_2
4
12%
Ph not_applicable
15
45%
Ph phase_1
1
3%

Phase Distribution

1

Early Stage

4

Mid Stage

11

Late Stage

Phase Distribution31 total trials
Phase 1Safety & dosage
1(3.2%)
Phase 2Efficacy & side effects
4(12.9%)
Phase 3Large-scale testing
11(35.5%)
N/ANon-phased studies
15(48.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

84.6%

22 of 26 finished

Non-Completion Rate

15.4%

4 ended early

Currently Active

2

trials recruiting

Total Trials

33

all time

Status Distribution
Active(3)
Completed(22)
Terminated(4)
Other(4)

Detailed Status

Completed22
unknown4
Terminated3
Active, not recruiting2
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
33
Active
2
Success Rate
88.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (3.2%)
Phase 24 (12.9%)
Phase 311 (35.5%)
N/A15 (48.4%)

Trials by Status

unknown412%
terminated39%
withdrawn13%
active_not_recruiting26%
completed2267%
enrolling_by_invitation13%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT01503632Phase 3

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Completed
NCT01824745Not Applicable

Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors

Active Not Recruiting
NCT00102011Phase 3

Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer

Completed
NCT07186530Not Applicable

Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening

Enrolling By Invitation
NCT03885817Not Applicable

Physically Active During Cancer Treatment (FAKT)

Active Not Recruiting
NCT01725165Phase 2

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Completed
NCT02715856Not Applicable

Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal Metastases

Terminated
NCT01550185Phase 1

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Terminated
NCT01235572Phase 2

Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy

Completed
NCT01360814

Structured Multidisciplinary Intervention or Standard Medical Care in Improving Quality of Life in Patients Receiving Active Cancer Treatment

Completed
NCT01999881Not Applicable

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Completed
NCT01519596Not Applicable

Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

Completed
NCT01553578Not Applicable

Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy

Completed
NCT01053494Not Applicable

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Completed
NCT02662335Not Applicable

Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors

Completed
NCT02345798Not Applicable

Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and Caregivers

Completed
NCT00863512Phase 3

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

Terminated
NCT02334332Not Applicable

Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery

Withdrawn
NCT00951626Not Applicable

A Standardized Nursing Intervention Protocol for HCT Patients

Completed
NCT00006231Phase 3

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
33